# EDGAR Filing Document

**Accession Number:** 0001839140
**File Stem:** 0001213900-26-008804
**Filing Date:** 2026-1
**Character Count:** 43172
**Document Hash:** 6ace6b5e3bf7d4ea84762d50a1fb2b5d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-008804.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001213900-26-008804

**CONFORMED SUBMISSION TYPE**: S-1/A

**PUBLIC DOCUMENT COUNT**: 17

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Revium Rx.
- **CENTRAL INDEX KEY:** 0001839140
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 844516676
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-1/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-284934
- **FILM NUMBER:** 26572404

**BUSINESS ADDRESS:**
- **STREET 1:** C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE
- **STREET 2:** SUITE 500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10151
- **BUSINESS PHONE:** 6467684285

**MAIL ADDRESS:**
- **STREET 1:** C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE
- **STREET 2:** SUITE 500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10151

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Revium Recovery, Inc.
- **DATE OF NAME CHANGE:** 20210105

As filed with the Securities and Exchange Commission on January 28, 2026

Registration No. 333-284934

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

Amendment No. 5 to

**FORM S-1**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

**<u>REVIUM Rx.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **2834** | **84-4516676** |
| (State or other jurisdiction of<br> Incorporation or organization) | (Primary Standard Industrial<br> Classification Code Number) | (I.R.S. Employer<br> Identification No.) |

---

**Amir Avraham**

**Azrieli Business Center**

**89 Medinat Hayehudim**

**Herzliya, Israel**

**<u>1 800 519-1687</u>**

(Address, including zip code, and telephone number, including area code,

of registrant's principal executive offices)

Copies to:

**David Aboudi, Esq.**

**Aboudi Legal Group PLLC**

**745 Fifth Avenue, Suite 500**

**New York, NY 10151**

**Telephone: (646) 898-2006**

**<u>From time to time after the effective date of this Registration Statement</u>**<br> (Approximate date of commencement of proposed sale to the public)

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box: ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

☐ Large accelerated filer ☐ Accelerated filer <br> ☒ Non-accelerated filer ☒ Smaller reporting company <br> ☒ Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.

**EXPLANATORY NOTE**

Revium Rx is filing this Amendment No. 5 to its Registration Statement on Form S-1 (File No. 333-284934) (the "Registration Statement") as an exhibits-only filing. Accordingly, this amendment consists only of the facing page, this explanatory note, the signature page to the Registration Statement and Item 16(a) of Part II of the Registration Statement (Exhibits Index) and the filed exhibits. The remainder of the Registration Statement is unchanged and has therefore been omitted.

**SIGNATURES**

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned in the city of Herzliya, Israel on January 28, 2026.

---

| | |
|:---|:---|
| **REVIUM RX.** | **REVIUM RX.** |
| By | /s/ Amir Avraham |
|  | Amir Avraham |
|  | Interim Chief Executive Officer |
|  | (Principal Executive Officer) |
| By | /s/ Arie Gordashnikov |
|  | Arie Gordashnikov |
|  | Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints David Akunis, as his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place and stead in any and all capacities, in connection with this Registration Statement, including to sign in the name and on behalf of the undersigned, this Registration Statement and any and all amendments thereto, including post-effective amendments and registrations filed pursuant to Rule 462 under the U.S. Securities Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorney-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement on Form S-1 has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Amir Avraham | Chief Executive Officer (Principal Executive Officer) | January 28, 2026 |
| Amir Avraham |  |  |
| /s/ Inna Martin | Chief Operating Officer, President, Secretary and Director | January 28, 2026 |
| Inna Martin |  |  |
| /s/ Arie Gordashnikov | Chief Financial Officer and Treasurer | January 28, 2026 |
| Arie Gordashnikov | (Principal Financial and Accounting Officer) |  |
| /s/ Bernard Bartal |  |  |
| Bernard Bartal | Chairman of the Board of Directors | January 28, 2026 |
| /s/ Matti Munk |  |  |
| Matti Munk | Director | January 28, 2026 |
| /s/ Yoram Drucker |  |  |
| Yoram Drucker | Director | January 28, 2026 |

---

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 2.1\* | [Stock Exchange Agreement by and among the Registrant, LipoVation and LipoVation's shareholders dated November 14, 2023](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex2-1_revium.htm) |
| 3.1\*\* | [Certificate of Incorporation of the Registrant in the State of Delaware on January 24, 1997 as a Delaware corporation under the name "Fun Cosmetic, Inc."](ea027444201ex3-1_revium.htm) |
| 3.2\*\* | [Certificate of Amendment to the Certificate of Incorporation of the Registrant dated August 29, 2005, changing the name from Fun Cosmetic, Inc. to Grand Canal Entertainment, Inc.](ea027444201ex3-2_revium.htm) |
| 3.3\* | [Certificate of Amendment to the Certificate of Incorporation of the Registrant dated October 14, 2008 changing the name of the Registrant from to Grand Canal Entertainment, Inc. to OC Beverages, Inc.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex3-3_revium.htm) |
| 3.4\* | [Certificate of Amendment to the Certificate of Incorporation of the Registrant dated December 9, 2020 changing the name of the Registrant from OC Beverages, Inc. to Revium Recovery, Inc. and implementing a 1-for-500 reverse split of the Company's Common Stock.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex3-4_revium.htm) |
| 3.5 \* | [Articles of Incorporation of the Registrant in the State of Nevada](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex3-5_revium.htm) |
| 3.6\* | [Plan of Conversion of the Registrant, dated December 17, 2024](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex3-6_revium.htm) |
| 3.7\* | [Certificate of Conversion filed with the State of Delaware](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex3-7_revium.htm) |
| 3.8\*\* | [Articles of Conversion filed with the State of Nevada](ea027444201ex3-8_revium.htm) |
| 3.9\* | [Bylaws of the Registrant in the State of Nevada](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex3-9_revium.htm) |
| 4.1\* | [Form of the IPO Warrants to be issued by the Company in this Offering](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex4-1_revium.htm) |
| 4.2\* | [Form of Investor Warrants issued by the Company in the First Private Placement Offering](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex4-2_revium.htm) |
| 4.3\* | [Form of Investor Warrants issued by the Company in the Second Private Placement Offering](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex4-3_revium.htm) |
| 5.1\* | [Opinion of Aboudi Legal Group PLLC](https://www.sec.gov/Archives/edgar/data/1839140/000121390026005242/ea027270001ex5-1_revium.htm) |
| 10.1\* | [License and Research Agreement between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective as of November 24, 2022 (Muprocin)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-1_revium.htm) |
| 10.2\* | [First Amendment to the License and Research Agreement Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective October 25, 2023 (Muprocin)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-2_revium.htm) |
| 10.3\* | [Second Amendment to the License and Research Agreement Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective October 25, 2023 (Muprocin)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-3_revium.htm) |
| 10.4\* | [License and Research Agreement between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective as of November 24, 2022 (OV)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-4_revium.htm) |
| 10.5\* | [First Amendment to the License and Research Agreement Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective October 25, 2023 (OV)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-5_revium.htm) |
| 10.6\* | [Research and Option Agreement effective as of October 25, 2023 (ARB)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-6_revium.htm) |
| 10.7\* | [Research and Option Agreement between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective as of March 16, 2021](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-7_revium.htm) |
| 10.8\* | [First Amendment to the Research and Option Agreement between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective as of June 8, 2021](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-8_revium.htm) |
| 10.9\* | [Second Amendment to the Research and Option Agreement between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. and LipoVation, effective as of August 1, 2021](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-9_revium.htm) |
| 10.10\* | [Form of Subscription Agreement executed by the Registrant and subscribers in the First Private Placement Offering](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-10_revium.htm) |
| 10.11\* | [Form of Subscription Agreement executed by the Registrant and subscribers in the Second Private Placement Offering](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-11_revium.htm) |
| 10.12\*\*@ | [Form of Engagement letter with Directors.](ea027444201ex10-12_revium.htm) |
| 10.13\*@ | [Employment Agreement dated as of February 1, 2024 between Inna Martin and Revium Ltd.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-13_revium.htm) |
| 10.14\*@ | [Consulting Agreement dated as of Dec 15, 2020 between Inna Martin and Revium Ltd.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-14_revium.htm) |
| 10.15\*@ | [Amendment to Consulting Agreement June 29, 2023 between Inna Martin and Revium Ltd.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-15_revium.htm) |
| 10.16\*@ | [Amendment to Consulting Agreement Dated December 24, 2024 between Inna Martin and Revium Ltd.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-16_revium.htm) |
| 10.17\*@ | [Employment Agreement dated as of December 18, 2024 between David Akunis and Revium Ltd.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex10-17_revium.htm) |
| 10.18\*@ | [Consulting Agreement dated as of February 26, 2024 between Revium Rx Ltd. and Amir Avraham](https://www.sec.gov/Archives/edgar/data/1839140/000121390025121070/ea026803401ex10-18_revium.htm) |
| 10.19\*@ | [Amendment to Consulting Agreement dated as of May 20, 2025.](https://www.sec.gov/Archives/edgar/data/1839140/000121390025121070/ea026803401ex10-19_revium.htm) |
| 21.1\* | [List of Subsidiaries](https://www.sec.gov/Archives/edgar/data/1839140/000121390025075747/ea025149001ex21-1_revium.htm) |
| 23.1\* | [Consent of Independent Registered Public Accounting Firm](https://www.sec.gov/Archives/edgar/data/1839140/000121390026005242/ea027270001ex23-1_revium.htm) |
| 23.3\* | [Consent of Aboudi Legal Group PLLC (included in Exhibit 5.1)](https://www.sec.gov/Archives/edgar/data/1839140/000121390026005242/ea027270001ex5-1_revium.htm) |
| 24.1\* | [Power of Attorney (included on signature page)](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea0230667-s1_revium.htm#poa_001) |
| 107\* | [Filing Fee Table](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/ea023066701ex-fee_revium.htm) |

---

\* Previously Filed

\*\* Filed Herewith

@ Management Contract or Compensatory Plan Arrangement.

## Exhibit 3.1

**Exhibit 3.1**

![](ex3-1_001.jpg)

Delaware The First State Page 1 2710797 8100 SR# 20260327115 You may verify this certificate online at corp.delaware.gov/authver.shtml Authentication: 202933657 Date: 01 - 28 - 26 I, CHARUNI PATIBANDA - SANCHEZ, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF "FUN COSMETICS, INC.", FILED IN THIS OFFICE ON THE TWENTY - FOURTH DAY OF JANUARY, A.D. 1997, AT 9 O`CLOCK A.M.

![](ex3-1_002.jpg)

CERTIFICATE OF INCORPORATION OF FUN COSMETICS, INC . S Z'£ OF' DEJA NARE SECRE'DAR Z OF' S'TA'TE DZ VZSZON OF' CORDORA'TZONS F'ZZ.ED 09 : 00 AI•I 02/24/2 997 9 72 0264 94 — 2 72 0 79 7 The undersigned, a natural person, for the purpose of organizing a corporation for conducting the business and promoting the purposes hereinaher stated, under the provisions and subject to the requirements of the laws of the State of Delaware (particularly Chapter 1 , Title 8 of the Delaware Code and the acts amendatory thereof and supplemental thereto, and known, identified, and referred to as the "General Corporation Law of the State of Delaware"), hereby certifies that : FIRST : The name of the corporation (hereinafter called the "corporation") is FUN COSMETICS, INC . SECOND : The address, including street, number, city, and county, of the registered office of the corporation in the State of Delaware is 1013 Centre Road, City of Wilmington 19805 , County of New Castle ; and the name of the registered agent of the corporation in the State of Delaware at such address is Corporation Service Company . THIRD : The purpose of the corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware . FOURTH : The total number of shares of stock which the corporation shall have authority to issue is ten million . The par value of each of such shares is one mill . All such shares are of one class and are shares of Common Stock . FIFTH: The name and the mailing address of the incorporator are as follows: NAME Merryl Wiener MAILING ADDRESS 375 Hudson Street, 11th Floor New York, New York 10014 SIXTH : The corporation is to have perpetual existence.

![](ex3-1_003.jpg)

SEVENTH : Whenever a compromise or arrangement is proposed between this corporation and in creditors or any class of them and/or between this corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in a summary way of this corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed for this corporation under † 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver or receivers appointed for this corporation under † 279 of Title 8 of the Delaware Code order a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this corporation, as the case may be, to be summoned in such manner as the said court directs . If a majority in number representing three fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of this corporation as consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class of creditors, and/or on all the stockholders or class of stockholders, of this corporation, as the case may be, and also on this corporation . EIGHTH : For the management of the business and for the conduct of the affairs of the corporation, and in further definition, limitation, and regulation of the powers of the corporation and of its directors and of its stockholders or any class thereof, as the case may be, it is further provided : 1. The management of the business and the conduct of the affairs of the corporation shall be vested in its Board of Directors . The number of directors which shall constitute the whole Board of Directors shall be fixed by, or in the manner provided in, the Bylaws . The phrase "whole Board" and the phrase "total number of directors" shaI 1 be deemed to have the same meaning, to wit, the total number of directors which the corporation would have if there were no vacancies . No election of directors need be by written ballot . 2. After the original or other Bylaws of the corporation have been adopted, amended, or repealed, as the case may be, in accordance with the provisions of † 109 of the General Corporation Law of the State of Delaware, and, after the corporation has received any payment for any of its stock, the power to adopt, amend, or repeal the Bylaws of the corporation may be exercised by the Board of Directors of the corporation ; provided, however, that any provision for the classification of directors of the corporation for staggered terms pursuant to the provisions of subsection (d) of † 141 of the General Corporation Law of the State of Delaware shall be set forth in an initial Bylaw or in a Bylaw adopted by the stockholders entitled to vote of the corporation unless provisions for such classification shall be set forth in this certificate of incorporation . 2 -

![](ex3-1_004.jpg)

3 . Whenever the corporation shall be authorized to issue only one class of stock, each outstanding share shall entitle the holder thereof to notice of, and the right to vote at, any meeting of stockholders . Whenever the corporation shall be authorized to issue more than one class of stock, no outstanding share of any class of stock which is denied voting power under the provisions of the certificate of incorporation shall entitle the holder thereof to the right to vote at any meeting of stockholders except as the provisions of paragraph (2) of subsection (b) of † 242 of the General Corporation Law of the State of Delaware shall otherwise require ; provided, that no share of any such class which is otherwise denied voting power shall entitle the holder thereof to vote upon the increase or decrease in the number of authorized shares of said class . NINTH : The personal liability of the directors of the corporation is hereby eliminated to the fullest extent permitted by the provisions of paragraph (7) of subsection (b) of j 102 a I the General Corporation Law of the State of Delaware, as the same may be amended and supplemented . TENTH : The corporation shall, to the fullest eztent permitted by the provisions of † 145 of the General Corporation Law of the State of Delaware, as the same may be amended and supplemented, indemnify any and all persons whom it shall have power to indemnify under said section from and against any and all of the expenses, liabilities, or other matters referred to in or covered by said section, and the indemnification provided for herein shall not be deemed exclusive of any other rights to which those indemnified may be entitled under any Bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such a person . ELEVENTH : Ftom time to time any of the provisions of this certificate of incorporation may be amended, altered, or repealed, and other provisions authorized by tire laws of the State of Delaware at the time in force may be added or inserted in the manner and at the time prescribed by said laws, and all rights at any time conferred upon the stockholders of the corporation by this certificate of incorporation are granted subject to the provisions of this Article ELEVENTH . Signed on January 22, 1997. - 3 - iene rporator

## Exhibit 3.2

**Exhibit 3.2**

![](ex3-2_001.jpg)

Delaware The First State Page 1 2710797 8100 SR# 20260327115 You may verify this certificate online at corp.delaware.gov/authver.shtml Authentication: 202933656 Date: 01 - 28 - 26 I, CHARUNI PATIBANDA - SANCHEZ, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF AMENDMENT OF "FUN COSMETICS, INC.", CHANGING ITS NAME FROM "FUN COSMETICS, INC." TO "GRAND CANAL ENTERTAINMENT, INC.", FILED IN THIS OFFICE ON THE TWENTY - NINTH DAY OF AUGUST, A.D. 2005, AT 11:13 O`CLOCK A.M.

![](ex3-2_002.jpg)

Randy Drew From: Filings To: 08/29/05 Date: DE Secretary of State At: I Pages: (Including Coversheet) (302)739 - 3812 Fax: Cc: Fun Cosmetics, Inc. File Number: 2710797 Re: To: DE SOS Page 2 of 4 2005 - 08 - Z9 15:13:51 (GMT) 2919 Grand Canal U'enice, CA 90291 (310) 402 - 76T6 [310) 861 - 8942 I'ax Randy Drew From: Lenka Danoff Attached are the Amended Articles of Incorporation for Fun Cosmetics, Inc. — File Number 2710797. Please apply credits from the Franchise Tax Account for all filing fees. If you need any additional information, please contact me anytime at (310) 402 - 7676. Sincerely, EXPEDITE DAY

![](ex3-2_003.jpg)

Df.i NOT WRITE IN THI S SPAC"E S U BMITTE R'S INFf.iRMAT ION Randy Drew «.» 2919 Grand Canal „, t„„ . m„, Venice, CA 90291 Attention. Randy Drew i.›, , 310 - 402 - 7676 ›„ 310 - 061 - 0942 DOC"U MENT FIL ING REQ UEST IN FO R MAT ION haJ e of 'o J \ pa \ › E.» , Fun Cosmetics, Inc. r,m„„„,t„ 2710797 „„„„, „,„„,t„ l \ ]›e ol hoc na... m Certificate of Amendment of Articles of Incorporation Fed - x OTH ER D0C"L1MENT FILING IN FO RMA TION Total $ encl osed C"0MM ENTS/ FILINCi INSTR£IC"TION S Card Type C li1'? l1l'l CA li11 IN1 O I‹MA I'I ON 1. SAME DAY EXPEDITE 2. RETURN VIA FEDEX 3. ALL FILING FEES FROM TAX ACCOUNT IN?'I'It Li6"I'IONS I . Each re‹Juest must be silbu itte‹l us a separale ileu", » itl i its own Oil ing hheet as th e FI NhT PAti c. To: DE SOS Page 3 of 4 Priority 1 (One hrs 2005 - 08 - Z9 15:13:51 (GMT) Randy Drew From: Lenka Danoff State of Delaware - Division of Corporations DOCUMENT FILING SHEET - Fax# 302/739 - 3812 Fr›zity 2 (Two Hr.) Friorit/ 3 (Same Day) (24 HQtir) (nag. Work)

![](ex3-2_004.jpg)

To: DE SOS Pape 4 of 4 2005 - 08 - Z9 15:13:51 (G MT) STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION Fun Cosmetics, Inc., a corporation organized and existing under and by virtue of the General Corporation Law (the "GCL") of the State of Delaware (the "Corporation"), DOES HEREBY CERTIFY: FIRST: That at a meeting of the Board of Directors of the Corporation, resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of said Corporation, declaring said amendments to be advisable and calling a meeting of the stockholders of said Corporation for consideration thereof. The resolution setting for the proposed amendments are as follows: RESOLVED, that the Certificate of Incorporation of this Corporate be amended by changing the Article thereof numbered "FIRST" so that, as amended, said Article shall be and read as follows: "The name of the Corporation is Grand Canal Entertainment, Inc." RESOLVED, that the Certificate of Incorporation of this Corporation be amended by changing the Article thereof numbered "FOURTH" so that, as amended, said Article shall be and read as follows: The aggregate number of shares of stock which the Company shall have authority to issue is 110,000,000, consisting of 100,000,000 shares of common stock, having a par value of $.001 per share (the "Common Stock"), and 10,000,000 shares of preferred stock, have a par value of $.01 per share (the "Preferred Stock"). The Preferred Stock may be issued from time to time in one or more senes. The Board of Directors is hereby authorized to create and provide for the issuance of shares of the Preferred Stock in series and by filing a statement pursuant to Article 151 of the GCL, to establish from time to time the number of shares in each such series, and to fix the designations, powers, preferences and rights of the shares of each such series and the qualification, limitations and restrictions thereof, including without limitation, the following: (a) the number of shares constituting that series and the distinctive designation of that series; (b) the dividend rate of the shares of that series, whether dividends shall be cumulative, and, if so, from which date or dates, and the relative rights of priority, if any, of payment of dividends on shares of that series; (c) whether that series shall have voting rights, in addition to the voting rights provided by law, and, if so, the terms of such voting rights; (d) whether that series shall have conversion privileges, and if so, the terms and conditions of such conversion, including provision for adjustment of the conversi9on rate in such events as the Board of Directors shall determine; (e) whether or not the shares of such series shall be redeemable, and if so, the terms and conditions of such redemptions, including the date or dates upon or after which they shall be redeemable, and the amount per share payable in case of redemption, which amount may vary under different conditions and at different redemption dates; (f) whether that series shall have a sinking fund for the redemption or purchase of shares of that series, and, if so, the terms and amount of such sinking fund; (g) the rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution or winding up of the corporation, and relative rights of priority, if any, or payment of such shares of that series; (b) any other relative rights, preferences and limitations of that series." That the capital of said Corporation shall not be reduced under or by reason of said amendments. SECOND: That thereafter, pursuant to resolution of its Board of Directors, a special meeting of the stockholders of said Corporation was duly called and held upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the necessary number of shares as required by statute were voted in favor of the amendments. THIRD: That said amendments were duly adopted in accordance with the provisions of Section 242 of the General Corporation Laws of the State of Delaware. IN WITNESS WHEREOF, said Corporation has caused this certificate to be signed by Randy Drew, an Authorized Officer this 29" day of August, 2005. By: Randy e Secretary Randy Drew From: Lenka Danoff

## Exhibit 3.8

**Exhibit 3.8**

![](ex3-8_001.jpg)

Entity Name: Revium Recovery, Inc. Jurisdiction: Delaware Entity Type\*: corporation If more than one entity being acquired or merging please attach additional page. 1 . Entity Information : (Constituent, Acquired or Merging) Entity Name: Revium Rx. Jurisdiction: Nevada Entity Type\*: corporation 2. Entity Information: (Resulting, Acquiring or Surviving) The entire plan of conversion, exchange or merger is attached to these articles. The complete executed plan of conversion is on file at the registered office or principal place of business of the resulting entity. The entire plan of exchange or merger is on file at the registered office of the acquiring corporation, limited - liability company or business trust, or at the records office address if a limited partnership, or other place of business of the acquiring entity (NRS 92A.200). The complete executed plan of conversion for the resulting domestic limited partnership is on file at the records office required by NRS 88.330. (Conversion only) 3. Plan of Conversion, Exchange or Merger: (select one box) Exchange/Merger: Owner's approval (NRS 92A.200) (options a, b or c must be used for each entity) A. Owner's approval was not required from the: Acquired/merging Acquiring/surviving B. The plan was approved by the required consent of the owners of: Acquired/merging Acquiring/surviving C. Approval of plan of exchange/merger for Nevada non - profit corporation (NRS 92A.160): Non - profit Corporations only: The plan of exchange/merger has been approved by the directors of the corporation and by each public officer or other person whose approval of the plan of merger is required by the articles of incorporation of the domestic corporation. Acquired/merging Acquiring/surviving Name of acquired/merging entity Name of acquiring/surviving entity 4. Approval: (If more than one entity being acquired or merging please attach additional approval page.) Date: Time: (must not be later than 90 days after the certificate is filed) 5. Effective Date and Time: (Optional) FRANCISCO V. AGUILAR Secretary of State 401 North Carson Street Carson City, Nevada 89701 - 4201 (775) 684 - 5708 Website: www.nvsos.gov www.nvsilverflume.gov ABOVE SPACE IS FOR OFFICE USE ONLY Articles of Conversion/Exchange/Merger NRS 92A.200 and 92A.205 This filing completes the following: Conversion Exchange Merger TYPE OR PRINT - USE DARK INK ONLY - DO NOT HIGHLIGHT \* corporation, limited partnership, limited - liability limited partnership, limited - liability company or business trust. Page 1 of 4 Revised: 8/1/2023

![](ex3-8_002.jpg)

Exchange/Merger: Owner's approval (NRS 92A.200) (options a, b or c must be used for each entity) A. Owner's approval was not required from the: Acquired/merging Acquiring/surviving B. The plan was approved by the required consent of the owners of: Acquired/merging Acquiring/surviving C. Approval of plan of exchange for Nevada non - profit corporation (NRS 92A.160): Non - profit Corporations only: The plan of exchange/merger has been approved by the directors of the corporation and by each public officer or other person whose approval of the plan of merger is required by the articles of incorporation of the domestic corporation. Acquired/merging Acquiring/surviving Name of acquired/merging entity Name of acquiring/surviving entity 4. Approval Continued: (If more than one entity being acquired or merging please attach additional approval page.) Exchange/Merger: Owner's approval (NRS 92A.200) (options a, b or c must be used for each entity) A. Owner's approval was not required from the: Acquired/merging Acquiring/surviving B. The plan was approved by the required consent of the owners of: Acquired/merging Acquiring/surviving C. Approval of plan of exchange for Nevada non - profit corporation (NRS 92A.160): Non - profit Corporations only: The plan of exchange/merger has been approved by the directors of the corporation and by each public officer or other person whose approval of the plan of merger is required by the articles of incorporation of the domestic corporation. Acquired/merging Acquiring/surviving Name of acquired/merging entity Name of acquiring/surviving entity 4. Approval Continued: (If more than one entity being acquired or merging please attach additional approval page.) FRANCISCO V. AGUILAR Secretary of State 401 North Carson Street Carson City, Nevada 89701 - 4201 (775) 684 - 5708 Website: www.nvsos.gov www.nvsilverflume.gov ABOVE SPACE IS FOR OFFICE USE ONLY Articles of Conversion/Exchange/Merger NRS 92A.200 and 92A.205 This filing completes the following: Conversion Exchange Merger TYPE OR PRINT - USE DARK INK ONLY - DO NOT HIGHLIGHT \* corporation, limited partnership, limited - liability limited partnership, limited - liability company or business trust. Page 2 of 4 Revised: 8/1/2023

![](ex3-8_003.jpg)

FRANCISCO V. AGUILAR Secretary of State 401 North Carson Street Carson City, Nevada 89701 - 4201 (775) 684 - 5708 Website: www.nvsos.gov www.nvsilverflume.gov Articles of Conversion/Exchange/Merger NRS 92A.200 and 91A.205 Name Country Care of: Address City State Zip/Postal Code 6.Forwarding Address for Service of Process: (Conversion and Mergers only, if resulting/surviving entity is foreign) 7. Amendment, if any, to the articles or certificate of the surviving entity. (NRS 92A.200): (Merger only) \*\* \*\* Amended and restated articles may be attached as an exhibit or integrated into the articles of merger. Please entitle them "Restated" or "Amended and Restated," accordingly. The form to accompany restated articles prescribed by the secretary of state must accompany the amended and/or restated articles. Pursuant to NRS 92 A . 180 (merger of subsidiary into parent - Nevada parent owning 90 % or more of subsidiary), the articles of merger may not contain amendments to the constituent documents of the surviving entity except that the name of the surviving entity may be changed . Exchange: The undersigned declares that a plan of exchange has been adopted by each constituent entity (NRS 92A.200). Merger: (Select one box) The undersigned declares that a plan of merger has been adopted by each constituent entity (NRS 92A.200). The undersigned declares that a plan of merger has been adopted by the parent domestic entity (NRS 92A.180). 8 . Declaration : (Exchange and Merger only) Conversion: A plan of conversion has been adopted by the constituent entity in compliance with the law of the jurisdiction governing the constituent entity. Signatures - must be signed by: 1. If constituent entity is a Nevada entity: an officer of each Nevada corporation; all general partners of each Nevada limited partnership or limited - liability limited partnership; a manager of each Nevada limited - liability company with managers or one member if there are no managers; a trustee of each Nevada business trust; a managing partner of a Nevada limited - liability partnership (a.k.a. general partnership governed by NRS chapter 87). 2. If constituent entity is a foreign entity: must be signed by the constituent entity in the manner provided by the law governing it. Revium Recovery, Inc. Name of constituent entity 9. Signature Statement: (Required) Form will be returned if unsigned. This form must be accompanied by appropriate fees. Page 3 of 4 Revised: 8/1/2023

![](ex3-8_004.jpg)

FRANCISCO V. AGUILAR Secretary of State 401 North Carson Street Carson City, Nevada 89701 - 4201 (775) 684 - 5708 Website: www.nvsos.gov www.nvsilverflume.gov Articles of Conversion/Exchange/Merger NRS 92A.200 and 91A.205 Exchange: Signatures - Must be signed by: An officer of each Nevada corporation; All general partners of each Nevada limited partnership; All general partners of each Nevada limited - liability limited partnership; A manager of each Nevada limited - liability company with managers or a member if there are no Managers; A trustee of each Nevada business trust (NRS 92A.230) Unless otherwise provided in the certificate of trust or governing instrument of a business trust, an exchange must be approved by all the trustees and beneficial owners of each business trust that is a constituent entity in the exchange. The articles of exchange must be signed by each foreign constituent entity in the manner provided by the law governing it (NRS 92A.230). Additional signature blocks may be added to this page or as an attachment, as needed. 9. Signature Statement Continued: (Required) Merger: Signatures - Must be signed by: An officer of each Nevada corporation; All general partners of each Nevada limited partnership; All general partners of each Nevada limited - liability limited partnership; A manager of each Nevada limited - liability company with managers or one member if there are no managers; A trustee of each Nevada business trust (NRS 92A.230). The articles of merger must be signed by each foreign constituent entity in the manner provided by the law governing it (NRS 92A.230). Additional signature blocks may be added to this page or as an attachment, as needed. Name of acquired/merging entity X Signature (Exchange/Merger) Title Date If more than one entity being acquired or merging please attach additional page of informaiton and signatures. 10. Signature(s): (Required) Name of acquiring/surviving entity X Signature (Exchange/Merger) Title Date X Signature of Constituent Entity (Conversion) Title Date Please include any required or optional information in space below: (attach additional page(s) if necessary) Form will be returned if unsigned. This form must be accompanied by appropriate fees. Page 4 of 4 Revised: 8/1/2023

## Exhibit 10.12

**Exhibit 10.12**

DATE

To:

**Re: <u>Director's Compensation Arrangements</u>**

REVIUM Rx., a Nevada Corporation (the "Company") is pleased to reaffirm your continued service as a director on the Board of Directors (the "Board") of the Company.

As compensation for your service on the Board, the Company is offering to you the following options. Please indicate your preference and return to the Company.

☐ ***Option A:***

In consideration for your services as a director during CALENDAR YEAR, the Company shall pay you an annual fee at the rate of $4,000.00, which shall be paid in accordance with the Company's regularly established practices regarding the payment of Directors' fees, or in increments of $2,000.00 biannually on each of June 1 and December 1.

In addition, you shall be paid (i) $500 for each Board meeting attended in person and (ii) $300 for each telephonic or virtual Board meeting or any Board action taken by way of written Board consent. The Company shall reimburse you for all reasonable business expenses incurred in the performance of Services in accordance with Company's expense reimbursement guidelines.

Subject to approval by the board of directors of the Company, the Company shall grant you a stock option under the ESOP (the "**Option**") to purchase up to 240,000 shares of the Company's common stock, par value $0.001 per share of the Company (the "**Common Stock**"). The Option shall vest over eight (8) consecutive fiscal quarters, beginning with the quarter ending _________. The Option shall be exercisable at a per share exercise price of $____ and shall otherwise be subject to the other terms and conditions specified in an Option Grant Agreement to be entered into between yourself and the Company.

☐ ***Option B:***

In consideration for your services as a director during CALENDAR YEAR, the Company shall pay you an annual fee at the rate of $8,000.00, which shall be paid in accordance with the Company's regularly established practices regarding the payment of Directors' fees, or in increments of $4,000.00 biannually on each of June 1 and December 1.

In addition, you shall be paid (i) $500 for each Board meeting attended in person and (ii) $300 for each telephonic or virtual Board meeting or any Board action taken by way of written Board consent. The Company shall reimburse you for all reasonable business expenses incurred in the performance of Services in accordance with Company's expense reimbursement guidelines.

Please return by email a copy of this letter signed as reflected below, indicating your preferred compensation arrangement. Upon receipt thereof, the Company will send to you a director agreement.

*[Signature page to follow]*

 

 

Sincerely,

Amir Avraham, Interim CEO

Agreed and Accepted:

By: